According to a research team in American, a newly discovered hormone could help to improve treatment amongst people with type 2 diabetes . The metabolic hormone, known as Adiponecti, serves to regulate a variety of processes. These include glucose regulation and also the metabolism of fat for energy production.
The recent research showed that the levels of hormone present amongst type 2 diabetics could help to predict the ways in which patients respond to some diabetes drugs .
The study, which is published in the online edition of Clinical Pharmacology and Therapeutics indicates that adiponectin could be used as a biomarker to monitor blood glucose tolerance.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Type 2 diabetes found to be a ‘significant risk factor’ among stroke victims

More evidence has been published which supports that diabetes is a “significant…

Conversation about doctors’ appointments occurring virtually rumbles on

More than half of GP appointments are still being delivered remotely in…

Public Health England considers low carb approach for type 2 diabetes

The low carb approach is being considered by the government to be…